197 related articles for article (PubMed ID: 25370920)
1. siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo.
Hu P; Chen X; Sun J; Bie P; Zhang LD
Biosci Rep; 2015 Jan; 35(1):. PubMed ID: 25370920
[TBL] [Abstract][Full Text] [Related]
2. SiRNA-mediated knockdown against NUF2 suppresses tumor growth and induces cell apoptosis in human glioma cells.
Huang SK; Qian JX; Yuan BQ; Lin YY; Ye ZX; Huang SS
Cell Mol Biol (Noisy-le-grand); 2014 Nov; 60(4):30-6. PubMed ID: 25481014
[TBL] [Abstract][Full Text] [Related]
3. Silencing of NUF2 inhibits tumor growth and induces apoptosis in human hepatocellular carcinomas.
Liu Q; Dai SJ; Li H; Dong L; Peng YP
Asian Pac J Cancer Prev; 2014; 15(20):8623-9. PubMed ID: 25374179
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.
Hu P; Shangguan J; Zhang L
Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769
[TBL] [Abstract][Full Text] [Related]
5. Silencing of NUF2 inhibits proliferation of human osteosarcoma Saos-2 cells.
Fu HL; Shao L
Eur Rev Med Pharmacol Sci; 2016; 20(6):1071-9. PubMed ID: 27049259
[TBL] [Abstract][Full Text] [Related]
6. KLF8 knockdown triggered growth inhibition and induced cell phase arrest in human pancreatic cancer cells.
Yi X; Li Y; Zai H; Long X; Li W
Gene; 2016 Jul; 585(1):22-27. PubMed ID: 26995652
[TBL] [Abstract][Full Text] [Related]
7. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer.
Lv S; Xu W; Zhang Y; Zhang J; Dong X
Int J Oncol; 2020 Dec; 57(6):1358-1367. PubMed ID: 33173994
[TBL] [Abstract][Full Text] [Related]
8. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
9. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
10. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo.
Guo J; Gao J; Li Z; Gong Y; Man X; Jin J; Wu H
Cancer Lett; 2013 Oct; 339(2):185-94. PubMed ID: 23791879
[TBL] [Abstract][Full Text] [Related]
12. Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers.
Jiang X; Jiang Y; Luo S; Sekar K; Koh CKT; Deivasigamani A; Dong Q; Zhang N; Li S; Hao F; Goh BKP; Ooi LL; Wang Y; Hui KM
Cancer Res Treat; 2021 Oct; 53(4):944-961. PubMed ID: 33421974
[TBL] [Abstract][Full Text] [Related]
13. The effects of cyclooxygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer cells.
Zhong Y; Xia Z; Liu J; Lin Y; Zan H
Oncol Rep; 2012 Apr; 27(4):1003-10. PubMed ID: 22200969
[TBL] [Abstract][Full Text] [Related]
14. Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells.
Li C; Ge M; Yin Y; Luo M; Chen D
Mol Cell Biochem; 2012 Nov; 370(1-2):127-39. PubMed ID: 22868929
[TBL] [Abstract][Full Text] [Related]
15. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model.
Takakura K; Shibazaki Y; Yoneyama H; Fujii M; Hashiguchi T; Ito Z; Kajihara M; Misawa T; Homma S; Ohkusa T; Koido S
PLoS One; 2015; 10(12):e0142981. PubMed ID: 26642349
[TBL] [Abstract][Full Text] [Related]
17. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
[TBL] [Abstract][Full Text] [Related]
18. B7-H3 overexpression in pancreatic cancer promotes tumor progression.
Zhao X; Li DC; Zhu XG; Gan WJ; Li Z; Xiong F; Zhang ZX; Zhang GB; Zhang XG; Zhao H
Int J Mol Med; 2013 Feb; 31(2):283-91. PubMed ID: 23242015
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer.
Lei Y; Tang L; Xie Y; Xianyu Y; Zhang L; Wang P; Hamada Y; Jiang K; Zheng W; Jiang X
Nat Commun; 2017 Apr; 8():15130. PubMed ID: 28440296
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo.
Li C; Chen D; Luo M; Ge M; Zhu J
Biotechnol J; 2014 May; 9(5):652-63. PubMed ID: 24799381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
